A detailed history of Diversified Trust CO transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Diversified Trust CO holds 32,587 shares of ACAD stock, worth $556,260. This represents 0.02% of its overall portfolio holdings.

Number of Shares
32,587
Previous 32,545 0.13%
Holding current value
$556,260
Previous $528,000 5.11%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$15.14 - $19.14 $635 - $803
42 Added 0.13%
32,587 $501,000
Q2 2024

Jul 16, 2024

BUY
$14.62 - $18.42 $24,561 - $30,945
1,680 Added 5.44%
32,545 $528,000
Q1 2024

Apr 18, 2024

BUY
$17.79 - $30.86 $32,484 - $56,350
1,826 Added 6.29%
30,865 $570,000
Q4 2023

Jan 08, 2024

SELL
$20.78 - $31.77 $11,865 - $18,140
-571 Reduced 1.93%
29,039 $909,000
Q3 2023

Nov 17, 2023

BUY
$20.84 - $33.47 $50,891 - $81,733
2,442 Added 8.99%
29,610 $617,000
Q2 2023

Jul 18, 2023

SELL
$17.8 - $25.65 $90,584 - $130,532
-5,089 Reduced 15.78%
27,168 $650,000
Q1 2023

Apr 07, 2023

BUY
$16.32 - $20.92 $104,627 - $134,118
6,411 Added 24.8%
32,257 $607,000
Q4 2022

Jan 17, 2023

SELL
$14.2 - $18.63 $6,787 - $8,905
-478 Reduced 1.82%
25,846 $411,000
Q3 2022

Oct 14, 2022

BUY
$14.11 - $18.27 $211 - $274
15 Added 0.06%
26,324 $431,000
Q2 2022

Jul 12, 2022

BUY
$13.01 - $27.22 $71,086 - $148,730
5,464 Added 26.21%
26,309 $371,000
Q1 2022

Apr 07, 2022

SELL
$20.94 - $27.5 $10,197 - $13,392
-487 Reduced 2.28%
20,845 $505,000
Q4 2021

Jan 13, 2022

SELL
$16.79 - $27.09 $36,870 - $59,489
-2,196 Reduced 9.33%
21,332 $498,000
Q3 2021

Jan 13, 2022

BUY
$15.78 - $24.77 $102,333 - $160,633
6,485 Added 38.05%
23,528 $391,000
Q2 2021

Jul 20, 2021

BUY
$19.4 - $27.42 $330,634 - $467,319
17,043 New
17,043 $416,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.